The product of the tumor suppressor gene p53 serves as a critical regulator of the cell cycle and plays a pivotal role in the surveillance of DNA damage (Levine, 1997) . However, a role in postmitotic neurons has also been suggested by the use of p53-null mice where neuronal damage was attenuated after either cerebral ischemia where infarct volume was reduced in both hetero-and homozygous animals (Crumrine et aI., 1994) , kainic acid treatment (Morrison et aI., 1996) or adrenalectomy (Sa khi et aI., 1996) . In addition, neurons cultured from such p53-deficient animals have less cell death after treatment with either glutamate or genotoxins (Enokido et aI., 1996; Xiang et aI., 1996) . In normal animals, increased its mRNA was efficiently translated in the ischemic cortex, but not striatum, by 8 to 24 hours of reperfusion. Western blotting confirmed 30-to 40-foJd increases in the full-length protein of 90 kd at these time points without evidence of alternative splic ing. Because Mdm2 is a negative regulator of the apoptosis promoting activity of p53, increased expression of Mdm2 may be a component of a repair response in injured neurons, and supports Mdm2 being an indicator of DNA damage in the brain early after an ischemic insult in a similar way to Gadd45. Key Words: mdm2-p53-Transient focal ischemia-Apoptosis Gene expression.
expression of p53 in neurons has been shown to be as sociated with various insults to the brain, e.g., ischemia (Chopp, et aI., 1992; Li et aI., 1994) , excitotoxicity (Sa khi et aI., 1994) , or adrenalectomy (Schreiber et aI., 1994) . Excitotoxic lesioning of rat brain with the N methyl-D-aspartate receptor agonist, quinolinic acid, also induces expression of p53 mRNA and protein in brain areas exhibiting DNA fragmentation (Hughes et aI., 1996) . In support of a positive role for p53 in induc ing neuronal cell death, overexpression of p53 in either cultured cortical, hippocampal, or superior cervical gan glion neurons leads to apoptosis (Jordan et aI., 1997; Slack et aI., 1996; Xiang et aI., 1996) , while overexpres sion of a dominant-negative truncated p53 protein pro tected neurons from spontaneous apoptotic death (Eizen berg et aI., 1996) .
As a transcription factor, p53, upregulates the activity of genes such as bax, gadd45, mdm2, and p21 (Holbrook et a!., 1996; Levine, 1997) . Carcinogenesis can arise from loss of p53 tumor-suppressor function due to mu tation, but also to overexpression of the cellular proto oncogene mdm2 whose product binds to wild-type p53 thereby preventing transactivation in an alternate manner (Momand and Zambetti, 1997) . Therefore, the Mdm2 protein regulates the p53 gene at the level of its activity, and the p53 protein regulates the mdm2 gene at the level of transcription, thus forming a p53-Mdm2 autoregula-tory feedback loop (Wu et aI., 1993; Kussie et aI., 1996; Momand and Zambetti, 1997) . p53-induced apoptosis has been shown to be prevented by Mdm2 in several cultured cell types (Chen et aI., 1996; Haupt et aI., 1996) suggesting that its p53 inhibitory effect may be critical in protecting neuronal cells from p53 mediated apoptosis.
Deletion of mdm2 in mice causes embryonic lethality, but this lethality can be rescued by the simultaneous knockout of p53 (Jones et aI., 1995; Montes de Oca Luna et aI., 1995) emphasizing the close functional interaction between Mdm2 and p53. However, an alternative possi bility may be that Mdm2 is not protective, but may in duce cell death because of its ability to increase the trans activation capability of E2FlIDPI (Martin et aI., 1995) which would exaggerate the capacity of E2F 1 itself to promote apoptotic cell death (Field et a!., 1996; Kowalik et aI., 1995) .
Expression of mdm2 is increased in response to many DNA damaging agents, e.g., ultraviolet light (Perry et aI., 1993) , gamma-radiation (Price and Park, 1994) , and cis platin (Kondo et aI., 1995) . After cerebral ischemia there is early DNA damage in the form of oxidized bases (PK Liu et aI., 1996) , and single-strand DNA-breaks (Tobita et aI., 1995; Chen et aI., 1997; Hou et aI., 1997 ) that could conceivably stimulate mdm2 expression. The ap pearance of single-strand DNA-breaks is known to in duce the accumulation of p53 and stimulate its binding activity (Lee et aI., 1995; Jayaraman and Prives, 1995) suggesting that this damage could be the cause of the increased p53 expression after an ischemic insult as well as the increase in gadd45 expression found after focal ischemia (Jin et aI., 1996; Hou et aI., 1997) , and prolif erating cell nuclear antigen (PCNA) expression after global ischemia (Tomasavic et aI., 1996) . Therefore, we undertook to study the expression of mdm2 in ischemic brain. In the present study, the expression pattern of mdm2 was investigated by semiquantitive reverse tran scriptase polymerase chain reaction (RT-PCR), in situ hybridization histochemistry, and immunohistochemical detection of Mdm2. These analyses show that mdm2 mRNA and protein expression were upregulated in a reperfusion-time-dependent manner after the ischemic episode.
MATERIALS AND METHODS
Focal ischemia by middle cerebral artery occlusion 
RT-PCR
Total RNA was extracted from dissected cortical areas of rat brain (n = 4) using TRIzol reagent (GIBCO-BRL Life Tech nologies, Burlington, ON, Canada). First strand cDNAs were reverse transcribed from 4 fLg of total RNA. The same amount of cDNAs were subsequently used for PCR amplification for a total of 25 cycles at 95°C for 1 minute, 60°C for 1 minute, and noc for 1 minute of each cycle. These optimal amplification conditions and cycle number were determined experimentally to ensure specific and linear signal generation, and expression of l3-actin mRNA was used as an internal standard as described before (Hou et aI., 1997) to quantify the relative amount of expression of mdm2. The PCR product was fractionated on a 2% agarose gel, photographed, and quantitated by scanning laser densitometry. The authenticity of every PCR product was confirmed by cloning into a pC R2.1 vector (Invitrogen Corp, San Diego, CA) and sequencing using an automated ABI 373A DNA sequencer.
In situ hybridization histochemistry
The procedure for in situ hybridization histochemistry was followed essentially as described by Robertson et al. (1995) with some modifications. Briefly, the rat brains were removed rapidly and frozen at -80°C after decapitation and dissection. 
Statistical analysis
All values are presented as mean ± SD. Statistical compari son of data from in situ hybridization histochemistry and West ern blotting were made by a two-factor analysis of variance (Duncan's test for multiple comparisons), and a level of P < .01
was considered statistically significant.
Immunohistochemistry
Rats were anesthetized with pentobarbital and transcardially perfused with heparinized sodium phosphate buffer (pH 7. and x-ray film. The intensity of the bands on the film were quantitated by scanning laser densitometry.
Immunoprecipitation and Western blotting

RESULTS
Design of primers for PCR amplification of rat mdm2
Because the sequence of the rat mdm2 gene is un known, a partial rat mdm2 cDNA sequence was obtained by PCR amplification of 601-bp fragment from rat brain cDNAs using a pair of degenerative primers designed from the conserved regions of human (Oliner et aI., 1992) and mouse (Fakharzadeh et aI, 199 1) mdm2 coding sequences (5'-GAT CAR TTY AGY GTR GAA TTT-3' and 5'-CAR ATC ACA CAW GGT TC-3'). The partial rat mdm2 sequence obtained represents about 40% of the sequence of the mouse mdm2 coding region and has a high nt homology (94%) to the mouse sequence. A num ber of internal rat specific mdm2 PCR primers were sub sequently made and their PCR products were cloned and the sequence verified. One pair of these primers was chosen to amplify the rat mdm2 for quantitation with a sequence of 5'-GTC TCT GGA CTC GGA AGA TTA C-3' and 5'-AAA CAA TGC TGC TGG AAG TCG-3'.
RT -PCR reveals increased mdm2 mRNA Expression of l3-actin mRNA was used as an internal standard to quantify the level of mdm2 expression be cause Northern blotting showed that l3-actin expression appeared unchanged within 24 hours of reperfusion in our hands (Hou et aI., 1997) , or in those of others (sum marized by Kumar and Wu, 1995) . The band amplified from the mdm2 primers which migrated as 46 1 bp was authenticated by cloning and sequencing (Fig. 1 A) . By measuring the relative intensity of this band compared to the internal standard, mdm2 mRNA expression appeared to increase slightly 1 hour after reperfusion in the isch emic neocortex after transient MCAO (n = 4) with maximal increases occurring at 6 hours of reperfusion compared to the contralateral side (Fig. 1 B) , and the level of expression appeared greater than those of sham animals for at least 24 hours.
In situ hybridization histochemistry shows increased mdm2 mRNA in neurons Specific antisense and corresponding sense mdm2 35-mer oligodeoxynucleotide probes were made to the 3' end of the rat mdm2 cDNA sequence (see Materials and Methods section). Increased in situ hybridization histo chemical labeling was observed primarily in the parietal cortex and dorsolateral striatum of the ischemic hemi sphere ( Fig. 2D ) with no signal observed in either the contralateral hemisphere (Fig. 2C ) or in sections from sham-operated animals ( Figs ver grains were seen in all layers of the cortex with no evidence of differential expression in the infarct core or penumbral region, and the area used for quantitation of mRNA expression is delineated in Figure 2D . Under higher power, counterstaining with cresyl violet indi cated that labeled cells were medium to large (20 to 30 /-lm in diameter) and therefore most likely neurons. In the ischemic cortex, the level of mdm2 mRNA expression began to increase after 1 to 8 hours of reperfusion after MCAO compared to the contralateral side (compare Figs. 3B and G; and Figs. 3C and H) , and the number of labeled cells reached a peak after 18 hours of reperfusion (Figs. 3D and 1 ), but after 24 hours of reperfusion the signal appeared to be reduced slightly (Figs. 3E and J) . The silver grains on sections from six ischemic animals at each time point were quantitated by image analysis and the number of mdm2-positive cells showed a signifi cant increase (P < .00 1) at 8, 18, and 24 hours of reper fusion compared to sham controls with the maximum of 20-fold at 18 hours (Fig. 4A ). There was a small apparent increase in the number of labeled cells in the contralat eral hemisphere compared to sham sections, but this was not statistically significant. The density of silver grains per cell also showed a significant increase with a five fold increase at 18 hours (Fig. 4B ). There appears to be a discrepency between the time course of changes in mdm2 mRNA as measured by RT-PCR (Fig. IB) and by in situ hybridization histochemistry (Fig. 4) . This is probably more apparent than real because the RT-PCR was performed on RNA extracted from entire cortical hemispheres which dilutes local changes, whereas the histochemic analysis was highly localized in the infarct ed region which emphasises any changes specific to the ischemic territory. In the dorsolateral striatum increased labeling was first observed at 8 hours (Figs. 5B and F), with larger increases occurring at 18 hours (Figs. 5C and G) and 24 hours (Figs. 5D and H). Quantitative analysis gave results similar to Figure 4 (not shown). In sections from sham-operated controls (n = 6) little, if any, label ing could be found in the cortex (Fig. 3A) or striatum (Fig. SA) . In situ hybridization histochemistry performed with the mdm2 sense probe failed to specifically label cells in brain sections at 1, 8, 24, (not shown) or 18 hours (Figs. 3F and 5E) of reperfusion after MCAO.
Reperfusion-time dependent increase of Mdm2 immunoreactivity
Immunohistochemical detection of Mdm2 was per formed on brain sections from sham-operated rats (n = 2), and reperfused rats at 1 hour (n = 2), 8 hours (n = 5), 24 hours (n = 11) and 48 hours (n = 2) after MCAO shown at relatively low magnification to show the extent of the area where increased protein staining was ob served (Fig. 6 ). Mdm2 immunoreactivity was increased in neurons but not glial cells nor blood vessel walls of the 662 y. TV ET AL.
A ischemic cortex. Moreover, under higher power it was observed that Mdm2 immunoreactivity was localized to the nucleus or perikaryon of neurons (Figs. 7 A-C), but also appeared in the processes of some cells (Figs. 7D  F) . No Mdm2 immunopositive staining was visible in sham controls (Fig. 6A) or the contralateral non occluded side (Figs. 6 F-H) . The appearance of Mdm2 immuno reactivity in the ischemic hemisphere occurred in a time dependent manner. At I hour of reperfusion, no Mdm2-positive neurons were detected (Fig. 6B) , but a few im munoreacti ve neurons appeared by 8 hours of reperfusion (Fig. 6C ) which increased in number and staining intensity by 24 hours (Fig. 6D) . At 48 hours of reperfusion, Mdm2 staining was significantly reduced (not shown). Despite the appearance of mdm2 mRNA in the dorsolateral striatum area seen above ( Fig. 5C and D), Mdm2 immunoreactivity was not detected (not shown).
In a further series of experiments, extracts from the entire ipsilateral or contralateral cortical hemispheres were immunoprecipitated with a Mdm2 monoclonal an tibody and subjected to analysis by Western blotting. At the same time, extracts from two human pancreatic can cer cell lines COLO-357 and T3M4, which are known to overexpress Mdm2 (Ebert et aI., 1994) , were used as positive controls. By this technique, Mdm2 protein with an apparent molecular mass of 90 kd similar to that ob served in the cancer cells was visualized in the extracts from sham cortex and at I hour in the ipsilateral side (Fig. 8A) . The amount of protein detected increased by 8 hours, and was further increased by 18 and 24 hours. The intensity of the bands from the separate experiments was quantified by scanning laser densitometry and shown to be consistent with the profile in the representative gel shown in Figure 8A (Fig. 8B) . The time course of Mdm2 protein expression in the ischemic cortex (n = 3; (B) I ncreased density of the hybridization signal per cell at various times of reperfusion. Data is the mean ± SD with n = 6 at each time point. Star indi cates statistical significance at P < .00 1 (analysis of variance. genes that have been found to be upregulated by this treatment including bax, bcl2, egr, los, gadd45, hsp, jun, mye, ngfi-C, nos, nurr, orp150, pena, and p53 (Akins et aI., 1996; Choi, 1996; Chopp and Li, 1996; Honkaniemi et aI., 1996; Iadecola, 1997; Linnik, 1996; MacManus and Linnik, 1997; Massa et aI., 1996) . These genes en code for several varieties of transcription factors, stress or repair proteins, anti-apoptotic proteins, and signal transducers such as nitric oxide synthase. The role of these gene products in the response to ischemia remains undefined, but may be considered to be either part of a protective or repair response, e.g., bcl-2, los, gadd45, hsp, jun, pena; or part of the active cell death machinery, e.g., bax, mye, or p53. The transcription factor p53 is of particular relevance here because of its demonstrated ability to induce apoptosis in neurons (Eizenberg et al., 1996; Jordan et al., 1997; Slack et al., 1996; Xiang et al., 1996) , and its increase in brain after either ischemia (Li et al., 1994; Tomasevic et al., 1996) or quinolinic acid treatment (Hughes et al., 1996) . In p53-null mice, a de crease in neuronal loss after several insults has been reported, e.g., after ischemia (Crumrine et al., 1994) , kainic acid treatment (Morrison et al., 1996) , or adrenal ectomy (Sakhi et al., 1996) . How p53 induces cell death is not known, but the genes that p53 transactivates in clude p21, gadd45, and mdm2 . Increases in gadd45 after either cerebral ischemia (Jin et al., 1996; Hou et al., 1997) or quinolinic acid treatment (Hughes et al., 1996) have already been reported. It may be considered odd that genes involved in cell-cycle control are expressed in postmitotic neurons, but the expression of such genes, as elegantly modeled in neurotrophin-deprived cultured J Cereh Blood Flow Metah, Vol. 18, No.6, 1998 sympathetic neurons (Johnson et al., 1995) , is echoed in the ischemic brain by the demonstration of increased cyclin D1, cdk4, and c-myc (Guegan et al., 1997; Li et al., 1997; Nakagomi et al., 1996; Wiessner et al., 1996) , and after kainic acid treatment by cyclin D 1 (W . In the present experiments after focal ischemia in rat brain, the expression of mdm2 mRNA and protein was increased in the ipsilateral cortex between 6 to 8 hours, and remained increased at 18 to 24 hours of reperfusion (Figs. 1, 3 , and 8) with no evidence of preferential ex pression in either the core or edges (penumbra) of the infarcted territory (Figs. 2 and 6 ). Increases in mdm2 gene expression have been found in response to DNA damage produced by a variety of genotoxins (Holbrook et al., 1996; Momand and Zambetti, 1997) . Irradiation of human fibroblast cells leads to DNA damage and a sub sequent increase in mdm2 mRNA (Price and Park, 1994) . The mdm2 gene is also inducible in a p53-dependent manner in cells treated with ultraviolet light, and the time of induction of mdm2 correlates with the recovery of normal rates of DNA synthesis (Perry et al., 1993) . Cis- platin treatment of human glioblastoma caused p53 and mdm2 overexpression and apoptosis while mdm2 anti sense oligonucleotide increased the susceptibility of the cells to the cisplatin-induced apoptosis (Kondo et ai., 1995) . After cerebral ischemia, both DNA damage in the form of oxidized bases and single strand breaks (Chen et ai., 1997; Hou et ai., 1997; PK Liu et ai., 1996; Tobita et ai., 1995) combined with evidence of DNA repair in the form of increased expression of PCNA (Tomasevic et ai., 1996) have been documented. This suggests that isch emically induced genomic damage may be the signal for the observed increased mdm2 gene expression in injured brain.
The mdm2 (murine double minute) oncogene was originally identified as a gene that was amplified and overexpressed in a tumorigenic derivative of mouse 3T3 cells, with the amplified sequences located on extrachro mosomal double-minute particles (Cahilly-Snyder et ai., 1987) , which subsequently can integrate into different chromosomes, such as chromosome 12q 13-14 in neuro blastoma (Corvi et ai., 1995) . The normal function of Mdm2 is to negatively regulate the transcriptional activ ity of p53 with the N-terminal 130 amino acids of Mdm2 required to physically block the transactivation domain of p53 thereby preventing downstream regulation of tar get genes (Chen et ai., 1993; Leng et ai., 1995; Momand and Zambetti, 1997 ). An additional component of the anti-p53 actions of Mdm2 is the ability of Mdm2 to target p53 for proteolytic destruction thereby ensuring termination of p53 signaling (Haupt et ai., 1997; Kub butat et ai., 1997) . The necessity of this negative regu lation can be seen by the lethality of knockout of mdm2 which can be overcome by concomitant knockout of p53 (Jones et ai., 1995; Montes de Oca Luna et ai., 1995) . Overexpression of mdm2 by gene amplification (Landa nyi et ai., 1993) can be seen as functionally equivalent to knockout of p53 suggesting that mdm2 acts as an onco gene in its own right (Levine 1997; Momand and Zam betti, 1997) . The human and mouse mdm2 genes encode polypeptides of 49 1 and 489 amino-acids, respectively, with an estimated molecular weight of 58 kd. Because of the large acidic domain in the C-terminal region of the protein, the full-length Mdm2 protein migrates as a single band with apparent molecular mass of 90 kd dur ing denaturing gel electrophoresis (Chen et ai., 1993) . In cancer cells, splice variants of mdm2 have been de scribed that yield many smaller proteins lacking the N terminal region that may be associated with more aggres sive tumor behavior (Gorgoulis et ai., 1996; Haines et ai., 1994; Olson et aI., 1993; Sigalas et ai., 1996) . However, in our present study using immunoprecipitation with a monoclonal antibody to the C-terminus of Mdm2, we show that only the 90-kd product was expressed in re sponse to the reperfusion insult and its level increased significantly by 8 hours of reperfusion reaching maxi mum expression by 18 h (Fig. 8) . This 90-kd protein is comparable in size to the full-length protein detected in human and mouse tissues, and is confirmed by data using Northern blotting of total RNA which also showed only the expression of the full-length mRNA transcript (not shown). This suggests that the upregulated Mdm2 in ischemic brain has the potential to inhibit the apoptotic activities mediated by p53. Evidence of neuronal apop tosis after either global or focal ischemia has been pre- Choi, 1996; Chopp & Li, 1996; Linnik, 1996; MacManus et ai., 1994 MacManus et ai., , 1995 Ni tatori et ai., 1995) , but it remains unclear as to whether this really is archetypal apoptosis with the requisite mor phologic and DNA fragmentation hallmarks (reviewed in MacManus and Linnik, 1997) . However, as indicated above, gene expression associated with apoptosis (e.g., bax, myc, and p53) in other cell types does occur in ischemic brain and so upregulated Mdm2 may be a brake on the cell death machinery in injured neurons. Such a protective role was proposed for another p53-related pro tein, Gadd45, which increases in nondamaged neurons after a period of focal ischemia (Jin et ai., 1996; Hou et ai., 1997) . In cultured cells, the ability of Mdm2 to re press cell death induced by p53 has been shown in both lung carcinoma and osteosarcoma cells (Chen et ai., 1996) or Hela and H1299 cells (Haupt et a!., 1996) . In addition, overexpression of Mdm2 protein by transfec tion into glioblastoma cells induced cellular resistance to cisplatin (Kondo et ai., 1995) . Because there was no preferential appearance of Mdm2 in the core or the edges (penumbra) of the isch emic tissue, and because more than 90% of the Mdm2-positive cells were shown to be dead at 18 to 24 hours by TdT-mediated dUTP-biotin nick-end labelling staining (not shown), an alternative to a protective role for Mdm2 has to be considered. Mdm2 can act in the complete absence of p53 and pRb to increase growth of human osteosarcoma cells (Dubspoterszman et aI., 1995) . Since the N-terminal half of Mdm2 is all that is required as the counter-weight to the actions of p53, additional functions may reside in the C-terminal half of the protein that contains a highly conserved acidic domain and putative DNA-binding zinc-finger regions (Levine, 1997; Mo mand and Zambetti, 1997) . Mdm2 can interact with the retinoblastoma tumor suppressor pRb (Xiao et ai., 1995) , and transcription factor E2Fl (Martin et ai., 1995) , which in turn can also bind pRb (Nevins, 1992) . This highly interactive group of proteins have normally been consid ered to be principally involved in cell cycle regulation. However, an alternative view is emerging in which E2Fl suppresses cell proliferation and induces apoptosis even in quiescent cells (Field et ai., 1996; Kowalik et ai., 1995) . Therefore, it is of interest that Mdm2 can increase the transactivation efficiency of E2Fl and thereby induce apoptosis (Martin et aI., 1995) . It is clear that there are complex direct and indirect interactions between Mdm2 and the products of many genes such as p53, p2 1, Gadd45, and PCNA in cycling cells whose expression also is changed after cerebral ischemia (Choi, 1996; Chopp and Li, 1996; MacManus and Linnik, 1997; To masevic et ai., 1996) . Whether Mdm2 is protective or promotes cell death via E2Fl may depend on the context of the mixture of these other interactive proteins in which Mdm2 finds itself. The relevance of the changes in Mdm2 shown herein to the ultimate demise of neurons is at present unclear, but several questions arise: Does Mdm2 respond in the presence of neuroprotective cir cumstances such as postischemic hypothermia; or is Mdm2 upregulation just an epiphenomen? Unfortu nately, the direct experiment of production of cerebral ischemia in mdm2-null mice to answer this latter question is not possible due to embryonal lethality of the gene knock out (Jones et ai., 1995; Montes de Oca Luna et ai., 1995) .
The exact balanced contribution of each of the inter active proteins mentioned above to the ultimate death of postmitotic neurons in the ischemic brain awaits much future work including the need for in vitro experiments with cultured neurons to directly manipulate gene ex pression. Whatever the outcome, it is now apparent that cell death after cerebral ischemia is at least partly gene directed. This at least offers the hope of future novel A therapeutic avenues based on modulation of apoptotic signaling. Finally, our findings indicate that mdm2 can be added to the expanding list of ischemic ally upregu lated genes in the brain such as bax, bcl2 , egr, jos, gadd45, hsp, jun, myc, ngfi-C, nos, nurr, orp150, pen a, and p53.
